Home Analyst Ratings Baird upgrades Walgreens Boots Alliance to Outperform rating with a $55...

Baird upgrades Walgreens Boots Alliance [WBA] to Outperform rating with a $55 price target

Baird took its Walgreens Boots Alliance [WBA] rating to the equivalent of Outperform from Neutral, and the price target to $55.0 from $41, in a research note dated 2021-01-11. That figure represents around a 21.65% premium from where the company’s shares closed on Friday. Other analysts also revised their coverage, with UBS’s analysts upgrading the shares from “a Sell” rating to “a Neutral” rating in a research note to investors issued in early April. Meanwhile, Deutsche Bank had raised its rating on WBA to “Hold” from the earlier “Sell”, in a research note produced for clients April 03, 2020. In addition, there was a downgrade from Wells Fargo on December 11, 2019. The rater changed WBA from “an Outperform” to “a Market perform”.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is Walgreens Boots Alliance Inc. [NASDAQ:WBA] a Good Buy Right Now?

It should be noted that WBA technical indicators for short, intermediate as well as long term progress have placed an overall average of 72% as Buy. The average signal changed from 24% Buy in the last week and compares with 24% Buy in the past month. Data from Walgreens Boots Alliance Inc.’s Trend Spotter indicated that the signals were Strengthening. The stock current average is 7.16 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 8.61 million shares while the medium term average advocated for 50% Buy. The average long-term signal stands at 50% Buy and the 100-day average volume stands at 7.7 million shares.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

WBA Price Performance

On Wall Street, Walgreens Boots Alliance Inc. [NASDAQ:WBA] finished Friday’s session down -0.11% at $45.21. The stock went up to $46.47 at the same session while its lowest single day price was $44.62. In the last five days, it saw a rise of about 13.37%, Walgreens Boots Alliance Inc. shares gained by almost 13.37% since the beginning of the year. However, the share price has dropped to as low as -20.40% below its one year high. On 01/07/21, the company shares recorded $46.71, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $39.94. The company’s shares have declined by -17.32% in the past year. The 50-day SMA achieved is $39.92 while the 200-day SMA is $40.26. Volume dropped to 9.9 million from 15.55 million in the previous session.

WBA Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 44.40 level, and in case of violation of this particular level, it will cause more drop to 43.58 level. On the upper level, 47.28 is still the key resistance. The stock may increase to the subsequent resistance at 46.25. The Relative Strength Index (RSI) pinned on the 14-day chart is 71.38, implying a overbought technical stance while the MACD stands at 3.47, meaning price will increase in the next trading period. Percent R indicator moved to 19.53%, implying bullish price movement. Stochastic %K at 84.17% suggest selling the stock.

What is the short interest in Walgreens Boots Alliance Inc.?

Short interest in the Walgreens Boots Alliance Inc. stock has plunged, decreasing by -1.02 million shares to total 16.96 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 15.94 million, data from Yahoo Finance shows. The increase of 6.01% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 2.37% of the overall float for the stock.

Walgreens Boots Alliance Inc.’s Biggest Shareholders: Who Owns Walgreens Boots Alliance Inc. [WBA]?

Filings by The Vanguard Group, Inc. showed that the firm now holds a total of 55,427,625 shares or roughly 6.40% of the outstanding WBA shares. This means their shares have reduced by -1,643,217 from the 55,427,625 the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, SSgA Funds Management, Inc. updated stake is worth $1,765,363,275. Details in the latest 13F filings reveal that BlackRock Fund Advisors acquired their 2.32% stake valued at $1,328,010,408 while The Caisse de dépôt et placement cut theirs at $611,385,719. During the last quarter, BlackRock Fund Advisors raised 792,898 of its shares in Walgreens Boots Alliance Inc. while The Caisse de dépôt et placement sold -31,600 shares. The Capital Research & Management Co’s holdings currently number 15,474,486 shares at $699601512.06. According to the firm’s last 13F report, Geode Capital Management LLC shares in the company at filing stood at 11,107,845 shares, roughly $422,209,188.

WBA Earnings Forecast For The Current Quarter

Walgreens Boots Alliance Inc. [WBA] is expected to report weak earnings results for the quarter ending on Feb 2021. Consensus estimates give the company expected revenues of $36.41B and an earnings per share of $1.19 for Feb 2021. Looking further ahead, the company is expected to report revenue of $36.61B at an EPS of $1.23 for May 2021. The estimates represent upside of 1.30% and 8.41% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

WBA Earnings Estimates For The Current Year

For the financial year, Walgreens Boots Alliance Inc. [NASDAQ:WBA] is expected to bring in revenue of $143.39B. The returns are nearly $3.85 billion higher than the company’s actual revenue recorded in the fiscal year 2020. In terms of EPS for the 2021, estimate put it at 4.83, higher than that of FY20 by $0.09. Estimates put this year’s earnings growth at 1.90%, 8.30% for the next, and at an annual 6.99% over the next 5-year period. As for sales, forecasts are for an increase of 2.80% in the current fiscal year and a further 1.30% over the following year.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why AbCellera Biologics Inc. (ABCL) stock faced negativity on Tuesday?

AbCellera Biologics Inc. (ABCL) shares lost 2.13% in after-hours on Tuesday, June 22, 2021, and closed the day at $21.60 per share. Earlier, ABCL's...

Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?

Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with...

Comstock Mining Inc. (LODE) stock soar during pre-market trading. What’s happening?

Comstock Mining Inc. (NASDAQ: LODE) stock gained by 1.14% at last close while the LODE stock price surged by 3.10% in the pre-market trading...

Why MediciNova Inc (MNOV) stock facing negativity since Monday’s after-hours?

MediciNova Inc. (MNOV) shares lost 5.71% in after-hours on Monday, June 21, 2021, and the plummeting continues in the pre-market session on Tuesday as...

Here is why Sanderson Farms Inc. (SAFM) stock rallied on Monday?

Sanderson Farms Inc. (SAFM) shares surged 10.16% in after-hours on Monday, June 21, 2021, and close the day at $183.50 per share. Earlier in...

Pyxis Tankers Inc. (PXS) stock fell during pre-market trading. Why so?

Pyxis Tankers Inc. (NASDAQ: PXS) stock declined by 0.06% at the last close while the PXS stock price plunged by 6.15% in the pre-market...

Why STAAR Surgical Company (STAA) stock went up on Tuesday?

STAAR Surgical Company (STAA) shares rose 5.84% in after-hours on Tuesday, June 22, 2021, and closed the day at $151.25 per share. earlier in...

Why AbCellera Biologics Inc. (ABCL) stock faced negativity on Tuesday?

AbCellera Biologics Inc. (ABCL) shares lost 2.13% in after-hours on Tuesday, June 22, 2021, and closed the day at $21.60 per share. Earlier, ABCL's...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam